Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.

about

Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.

P2860

Q49231401-F98FC498-45E2-425B-AF10-A59EDA21C500

P2860

Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.

Item

http://www.wikidata.org/entity/Q39332694

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immune-related neurological to ...... hibitors: a systematic review.

@en

Immune-related neurological to ...... hibitors: a systematic review.

@nl

type

Item

label

Immune-related neurological to ...... hibitors: a systematic review.

@en

Immune-related neurological to ...... hibitors: a systematic review.

@nl

prefLabel

Immune-related neurological to ...... hibitors: a systematic review.

@en

Immune-related neurological to ...... hibitors: a systematic review.

@nl

P1476

Immune-related neurological to ...... hibitors: a systematic review.

@en

P2093

Anwar Giryes

http://www.w3.org/2001/XMLSchema#string

Daniel Helbling

http://www.w3.org/2001/XMLSchema#string

Hani Oweira

http://www.w3.org/2001/XMLSchema#string

Jan Schmidt

http://www.w3.org/2001/XMLSchema#string

Michael Decker

http://www.w3.org/2001/XMLSchema#string

Mostafa Eltobgy

http://www.w3.org/2001/XMLSchema#string

Omar Abdel-Rahman

http://www.w3.org/2001/XMLSchema#string

Othmar Schöb

http://www.w3.org/2001/XMLSchema#string

Ulf Petrausch

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.

Lambrolizumab induced central nervous system (CNS) toxicity.

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

P304

725-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737175.2017.1336088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arianeb Mehrabi

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28548892

http://www.w3.org/2001/XMLSchema#string

Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.

about

P2860

P2860

Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698